| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.008 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |